Connect with us

Hi, what are you looking for?


Charles Schwab stock outlook: JPMorgan analyst sees 60% upside

U.S. banks have been under a lot of pressure lately but a JPMorgan analyst is still convinced that investing in Charles Schwab Corporation (NYSE: SCHW) at current levels positions you for lucrative returns.

Charles Schwab stock could climb to $85

Kenneth Worthington reiterated the financial service company at “overweight” this week. His $85 price target suggests about a 60% upside from here.

The bullish call on Charles Schwab stock arrives only days after it reported better-than-expected earnings for its first financial quarter with review printing in line with Street estimates (source).

Last month, the Westlake-headquartered firm had reiterated it was sound in terms of liquidity and wasn’t struggling with the same challenges that ultimately led to the failure of the Silicon Valley Bank.  

“SCHW” is currently down close to 35% for the year.

Charles Schwab has the option to de-bank

Even if push comes to shove, Worthington said in his research note, Charles Schwab retains the option to pull out of banking services that would warrant a higher multiple for this financial stock.

Schwab could theoretically de-bank, and return to operating the way it did historically, which was a focus on sweeping cash into money market funds and earnings an elevated management fee rather than an even larger spread.

It would be the last resort for Schwab, though, that would ideally try to avoid winding down since it could result in a massive hit to earnings, the analyst concluded.

Charles Schwab stock currently pays a dividend yield of 1.86% that makes up for an additional reason to own it.

The post Charles Schwab stock outlook: JPMorgan analyst sees 60% upside appeared first on Invezz.

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Latest News

    Rep. Jennifer Wexton (D-Va.) announced on Tuesday that she has been diagnosed with Parkinson’s Disease. “If there’s one thing that Democrats and Republicans can...

    Latest News

    After Dianne Feinstein announced she’d contracted the shingles in early March, her staff said she planned to return to the Senate within a matter...


    A U.S. District Court judge has ruled that Elizabeth Holmes, founder and CEO of the disgraced blood-testing company Theranos, cannot remain free on bail...

    Latest News

    SEOUL, South Korea — When a group of American lawmakers arrived in South Korea for meetings with government and military officials, President Yoon Suk-yeol...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2022 All Rights Reserved.